Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SIBUTRAMINE HYDROCHLORIDE
- Efficacy and Safety of Sibutramin-containing Drugs in Patient With Alimentary Obesity
- Effects of Paroxetine on Cardiovascular Function in Septic Patients
- A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight
- Study of Atomoxetine in the Prevention of Vasovagal Syncope
- Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope
- Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope
- A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese Subjects
- The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS)
- Effects of Clopidogrel and Clarithromycin on the Oral Disposition of Sibutramine in Healthy Subjects
- Assess the Additional Weight Loss Effect of Orlistat Used in Combination With Sibutramine
- Studying the Effects of Sibutramine on Eating Behavior
- A Weight Loss Study in Overweight Men and Women
- Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese Patients
- A Functional Magnetic Resonance Imaging (fMRI) Study in Overweight and Obese Men (0000-103)
- Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care
- Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia
- Chromium Piccolinate in the Prevention of Weight Gain Induced by Serotonergic Medications Initiated on Psychiatric Inpatient Units.
- Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) Patients
- Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives
- Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population
- Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects
- Treatment of Binge Eating in Obese Patients in Primary Care
- A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects
- Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)
- Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS
- A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program
- Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited Genes
- A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder
- A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects
- Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity
- A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.
- A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.
- A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients
- Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity
- Adolescent Weight Management Study
- A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects
- The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder
- Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates
Clinical trials list
click for details